Chinese Academy of Medical Sciences Medical and Health Science and Technology Innovation Project(2023-I2M-C&T-B-094);Beijing Nova Program(20230484277);National key research and development program(2023YFC2508500).
Chimeric Antigen Receptor(CAR)T-cell therapy has shown significant success in hematological cancers,leading to the approval of several products and underscoring the potential of immunotherapy in cancer treatment.Howev...
Pancreatic ductal adenocarcinoma(PDAC)remains one of medicine’s most urgent areas of unmet need.With 5-year survival rates of∼11%,PDAC is set to become the second leading cause of cancer related deaths by 2040[1].Th...
Supported by Innovation Grants DAPCM(232129,245130);President and Fellows of Harvard College Myles shore fellowship(241317)to Y.J.S.C;supported by Scientific Research Funds of Zhejiang Province Health Department 2024ky205;Hangzhou Agricultural and Social Development Key Scientific Research Project 202004A19;supported by Guizhou Province Science Technology Project(2024)051.
Natural killer(NK)cells,initially identified for their rapid virus-infected and leukemia cell killing and tumor destruction,are pivotal in immunity.They exhibit multifaceted roles in cancer,viral infections,autoimmuni...
When Tom Dambudzo was bedridden due to ill health in his rural village,taking painkillers was the only option for him to relieve pain.“I couldn’t walk properly when I had severe backache for six months and my depend...
Myocarditis is a rare cardiomyocyte inflammatory process,typically caused by viruses,with potentially devastating cardiac sequalae in both competitive athletes and in the general population.Investigation into myocardit...
supported by the Guangxi Zhuang Autonomous Region Program of China(No.Z-C20220797);Guangxi Science and Technology Planning Project of China(No.Guike AD20297047);National Natural Science Foundation of China(No.81902849).
Objective Abnormal expression of T-lymphokine-activated killer cell-originated protein kinase(TOPK)was reported to be closely related to the resistance of prostate cancer to radiotherapy and to targeted drug resistanc...
supported by the National Natural Science Foundation of China(grant numbers 82170188 and 81970176);Guangdong Basic and Applied Basic Research Foundation(grant number 2021A1515110012).
Anti-PD-1 antibodies are a favorable treatment for relapsed or refractory extranodal natural killer T cell lymphoma(RR-ENKTL),however,the complete response(CR)rate and the duration of response(DOR)need to be improved....
supported,in part,by research funding from the National Natural Science Foundation of China (82130004 and 82270194);National key research and development program (2022YFC2502600);Chang Jiang Scholars Program,Shanghai Rising-Star Program (23QA1406100);Shanghai Municipal Commission of Science and Technology Project (23141903100);Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support (20152206,20152208,and 20161303);Clinical Research Plan of Shanghai Hospital Development Center (SHDC 2020CR1032B);Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine (DLY201601)。
Natural killer T cell lymphoma(NKTCL)is highly aggressive,with advanced stage patients poorly responding to intensive chemotherapy.To explore effective and safe treatment for newly diagnosed advanced stage NKTCL,we co...
Objective To analyze the relationship between killer cell immunoglobulin-like receptor (KIR) genes and immune reconstitution failure in human immunodeficiency virus infection/acquired immunodeficiency syndrome (HIV/AI...
supported by the Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology(Grant No. ZLJZZDYYWZL04);the Clinical Oncology Research Fund of CSCO(Grant No. Y-SY2021MS-0240);the Haihe Yingcai(Tianjin)Project(Grant No. TJSJMYXYC-D2-039);the Tianjin Key Medical Discipline(Specialty)Construction Project grant(Grant No. TJYXZDXK-009A);the CACA-BeiGene Lymphoma Research Foundation(Grant No.CORP-117)。
Mature T-and natural killer(NK)-cell lymphomas are heterogeneous groups of malignant lymphoid neoplasms arising from T and NK cells. The incidence of mature T-and NK-cell lymphomas is 2.1 per 100,000 people, according...